B2B Expansion 2026
Secure Your Exclusive Clinical Skincare Territory
Barekyne is granting exclusive monopoly rights to serious B2B pharma investors and distributors across India's highest-growth dermatology markets.
15
Cities
100+
Districts
5
SKUs
WHO-GMP Certified
50%+ Distributor Margins
Dermatologist Formulated
District-Level Monopoly
Select Your Target Market
Click on a city to view detailed market insights, available districts, and territory status.
0+
Cities Active
Across India
0+
Districts Open
Monopoly territories
0
Clinical SKUs
High-velocity portfolio
>0%
Distributor Margin
Industry-leading ROI